A Phase II Clinical Trial to Evaluate the Potential of Concomitant Chemoradiotherapy With Gemcitabine in Patients With Locally Advanced Carcinoma of Cervix and Renal Disease
Phase of Trial: Phase II
Latest Information Update: 02 Apr 2018
At a glance
- Drugs Gemcitabine (Primary)
- Indications Adenocarcinoma; Cervical cancer; Renal failure; Squamous cell cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 28 Mar 2018 Planned primary completion date changed from 31 Jan 2018 to 30 Mar 2019.
- 28 Mar 2018 Status changed from not yet recruiting to recruiting.